TWiV 934: Clinical update with Dr. Daniel Griffin

In his weekly clinical update Dr. Griffin discusses variant influenza virus infections: recommendations for identification, treatment, and prevention for summer and fall 2022, low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individuals, using the right tools at the right time for SARS-COV-2 infection, onset and window of SARS-COV-2 infectiousness and temporal correlation with symptom onset, transmission of SARS-COV-2: a review of viral, host, and environmental factors, antibody persistence and safety through 6 months after heterologous orally aerosolized Ad5-nCoV in individuals primed with two-dose vaccine, timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients, administration of anti–SARS-COV-2 monoclonal antibodies after US Food and Drug Administration deauthorization, and clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode 2022 recommendations for Influenza infections (CDC) Low levels of monkeypox neutralizing antibodies after vaccination (medRxiv) Using the right tools during SARS-CoV-2 infection (ESMED) Onset and window of SARS-CoV-2 infectiousness with symptom onset (The LANCET) Transmission of SARS-COV-2 (ACP Journals) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Administration of anti–SARS-COV-2 monoclonal antibodies (JAMA) Clinical and genetic risk factors for thromboembolism (JAMA) Administration of tocilizumab improves outcomes (PLOS One) Antibody persistence and safety through 6 months (medRxiv) Improve risk score for thromboembolism (mdCalc) Contribute to Floating Doctors fundraiser at PWB Dr. Griffin’s treatment guide (pdf) Letters read on TWiV 934 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]